Free tools Windows power users keep installed
One-click scans. No signup required.
Evaluate a drug-response model against a precisely defined prediction task, response endpoint, dataset and intended use. Keep preprocessing and splits identical across models, include simple baselines, report aggregate and per-drug results, and test on independent datasets whenever you claim transfer. Treat cell-line scores as preclinical predictive evidence—not proof that patients will benefit.
Start by defining what the model is supposed to predict
A score has no meaning until its prediction target and use case are explicit. “Drug response” can mean a continuous sensitivity value, a binary sensitive/resistant label, a ranking of drugs for each biological sample, or the effect of a drug combination. These are different tasks and require different labels, splits and metrics.
As an Amazon Associate I earn from qualifying purchases.
Specify the biological unit
State whether each prediction concerns a cancer cell line, a patient-derived sample, a tumor biopsy or another unit. Cell-line studies are controlled preclinical experiments; they are not interchangeable with patient-level validation. Also state whether the model predicts for cell lines seen during training, new cell lines, new drugs, or both.
Name the response endpoint exactly
Identify the measured endpoint, such as an IC50 estimate, area under the dose–response curve (AUDRC), viability at a specified concentration, or a derived sensitivity class. Include the assay protocol, dose range and normalization method when available. IC50 and AUDRC values that share a name can still be non-comparable if studies use different concentrations, curve-fitting procedures or response definitions.
#1 Best Overall
- Read Before You Buy — No Video Output: These adapters support charging and USB 2.0 data transfer, but cannot transmit video signals. Except for standard USB webcams (which use USB data only), they are not compatible with HDMI/DisplayPort cables, video-capable USB-C hubs, or docking stations with video output.
- Convert USB-A Ports to USB-C: Designed to connect USB-C earphones, cables, flash drives, card readers, and other USB-C accessories to standard USB-A ports. Plug-and-play with no drivers or software required.
- Aluminum Alloy Housing: Built with a sturdy aluminum alloy shell that aids in heat dissipation and protects against daily wear and scratches. Designed to maintain a stable and secure connection.
- Compact & Travel-Friendly: The ultra-compact design allows the adapter to stay plugged into your device without blocking adjacent ports or adding bulk, reducing wear and tear on your original USB ports.
- 12-Month Warranty: Backed by a 12-month manufacturer warranty for peace of mind. Designed to meet strict quality control standards for reliable everyday performance.
Connect the endpoint to a decision
Explain what a correct prediction would enable: estimate a continuous response, rank candidate single agents, classify samples for a treatment threshold, or prioritize combinations for follow-up. A model that has the best correlation may not be the best tool for selecting the top three drugs, and a classifier calibrated for one threshold should not silently be used with another.
Build a fair comparison before training
Model comparisons are credible only when competing methods receive equivalent information and are evaluated on equivalent observations. The 2026 benchmark by Partin and colleagues identifies inconsistent dataset composition, data splits and metrics as major barriers to fair comparisons and standardizes the workflow across seven drug-response models and five public drug-screening datasets.
Freeze the data pipeline
- Use the same response records, molecular features, omics inputs and drug representations for every compared model unless the comparison explicitly studies input modalities.
- Apply preprocessing, imputation, scaling, feature selection and dimensionality reduction inside the training portion of each split. Fitting these steps on all data leaks information from the test set.
- Document duplicate handling, missing responses, failed assays, replicate aggregation and any response-value transformations.
- Keep the response endpoint and units unchanged across models. If harmonization is necessary, publish the rule and identify which records were excluded.
Include meaningful baselines
Compare complex neural or foundation models with straightforward baselines that use the same split and inputs. A baseline can be a global mean, a drug-wise or cell-line-wise mean, regularized linear regression, or another simple method appropriate to the endpoint. If a sophisticated model does not beat a baseline on the intended test, the extra complexity has not demonstrated value.
Prevent hidden information leakage
Check that a cell line, drug, dose-response replicate or near-duplicate molecular profile cannot appear in both training and test data in a way that reveals the answer. Record whether related compounds, repeated assays or measurements from the same study are grouped together. Leakage can produce impressive in-dataset scores while failing on a genuinely new experiment.
Choose a split that matches the claim
The split determines the question your score answers. A random holdout estimates performance on observations resembling the source dataset. It does not establish that the model transfers to another laboratory, assay or study.
| Intended claim | Appropriate evaluation design | What the result supports | What it does not support |
|---|---|---|---|
| Predict additional records from the same study | Random or stratified holdout, with leakage controls | In-domain prediction for similarly sampled records | Transfer to a new study, assay or dose range |
| Predict a new cell line | Group the held-out cell line so none of its records enter training | Generalization across biological samples | Generalization to unseen drugs or protocols |
| Predict a new drug | Hold out all responses for the drug, using a documented drug split | Generalization to compounds not represented in training | Performance on a new assay context unless separately tested |
| Transfer to another screening study | Train on one dataset and test on an independent dataset; report the relative drop from within-dataset performance | Cross-dataset robustness under the tested conditions | Universal performance across all laboratories or patient populations |
| Support a clinical decision | Patient-level external validation with a prespecified clinical endpoint | Only the clinical association demonstrated by that study | Clinical benefit based solely on cell-line benchmarks |
State exactly which drugs, cell lines and datasets are held out. If a test set is reused for model selection, it is no longer an untouched final test; use a validation set or nested procedure for tuning and reserve the final test for one locked evaluation.
Rank #2
- 5-in-1 USB-C Hub: Experience comprehensive connectivity featuring a Power Delivery input, two USB-A 2.0 ports, a USB-A 3.0 port, and an HDMI port. (Note: The USB-C power delivery input port is only for connecting an external wall charger to power your laptop and cannot power peripheral devices.)
- 90W Pass-Through Charging: Achieve optimal charging with 90W pass-through power to your laptop, supported by a total input of 100W, with the hub reserving 10W for operational efficiency. (Note: Wall charger not included.)
- Quick Data Transfers: Accelerate your productivity with rapid data transfers using a high-speed 5Gbps USB 3.0 port and two 480Mbps USB 2.0 ports.
- 4K HDMI Display: Enhance your visual experience with a hub capable of delivering 4K resolution at 30Hz in both mirror and extend modes. Please note that this hub is compatible with MacBook (macOS 12 and newer), Windows 10 and 11, ChromeOS, and laptops equipped with DP Alt Mode and Power Delivery. Note: This device is not compatible with Linux.
- What You Get: Anker USB-C Hub (5-in-1, 4K HDMI), welcome guide, 18-month warranty, and our friendly customer service.
Match metrics to the prediction output
Name the metric, its direction (higher or lower is better), the unit or scale, and how values were aggregated. Different studies can report “accuracy” or a correlation while measuring different tasks, making an unexplained headline score unsuitable for comparison.
| Task | Useful metric families | Interpretation to report | Important cautions |
|---|---|---|---|
| Continuous response regression | Pearson or Spearman correlation; MAE, RMSE or another stated error measure | Whether predictions track measured responses and how far they deviate | Correlation can be high despite systematic bias; error depends on the response scale |
| Binary sensitivity classification | AUROC, area under the precision–recall curve, sensitivity, specificity, balanced accuracy and calibration measures | Discrimination, performance at the chosen threshold and probability reliability | Class imbalance can make plain accuracy misleading; thresholds must be prespecified |
| Drug prioritization or ranking | A ranking metric suited to the number of recommendations and a stated top-k rule | Whether the model places useful candidates near the top | A good global correlation does not guarantee a useful top-ranked list |
| Combination-effect prediction | A metric defined for the chosen synergy or response model | Agreement with the combination endpoint and decision threshold | Combination prediction is a distinct task; single-agent scores cannot be transferred automatically |
Show confidence intervals or variability across repeated splits when feasible, and disclose whether an aggregate is a mean, median, weighted score or pooled calculation. Report the number of test observations behind every summary. A single average can hide unstable or clinically important failures.
Always report overall and per-drug performance
Aggregate performance is necessary but insufficient. The review Foundation models and deep learning for cancer drug response prediction: a framework for data, metrics, and validation states that drug-response prediction models should be evaluated both overall and on a per-drug basis.
What to include for each drug
- Number of test responses and the response range.
- The chosen metric with its direction and uncertainty.
- Performance relative to the same baseline.
- Whether the drug was represented in training and, if so, at what level.
- Any assay, dose-range or missingness characteristic that limits interpretation.
Present the distribution across drugs—such as a median, interquartile range and worst-performing subgroup—in addition to the overall value. A model that wins on average because of a few heavily measured drugs may be unsuitable for an underrepresented treatment.
Inspect biological and technical subgroups
Stratify where the intended use requires it: tissue lineage, mutation status, dose range, study site, assay batch or response prevalence. Keep subgroup analyses prespecified when possible. Very small subgroups should be labeled as uncertain rather than treated as definitive rankings.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Test transfer on independent datasets
When the intended use involves new data, train and tune on one dataset, lock the model and evaluate it on an independent dataset that differs in study or assay context. Describe the direction of transfer, the overlapping drugs or cell lines, and the records removed because labels or features were unavailable.
Rank #3
- Sleek 7-in-1 USB-C Hub: Features an HDMI port, two USB-A 3.0 ports, and a USB-C data port, each providing 5Gbps transfer speeds. It also includes a USB-C PD input port for charging up to 100W and dual SD and TF card slots, all in a compact design.
- Flawless 4K@60Hz Video with HDMI: Delivers exceptional clarity and smoothness with its 4K@60Hz HDMI port, making it ideal for high-definition presentations and entertainment. (Note: Only the HDMI port supports video projection; the USB-C port is for data transfer only.)
- Double Up on Efficiency: The two USB-A 3.0 ports and a USB-C port support a fast 5Gbps data rate, significantly boosting your transfer speeds and improving productivity.
- Fast and Reliable 85W Charging: Offers high-capacity, speedy charging for laptops up to 85W, so you spend less time tethered to an outlet and more time being productive.
- What You Get: Anker USB-C Hub (7-in-1), welcome guide, 18-month warranty, and our friendly customer service.
Measure both absolute performance and performance drop
Report the in-dataset score and the external score side by side, then quantify the relative or absolute drop using a clearly stated formula. A large drop is not merely a disappointing number; it reveals sensitivity to protocol, population or feature distribution changes.
Interpret the 2026 benchmark correctly
Partin and colleagues evaluated seven standardized models across five public drug-screening datasets. Their study found substantial performance declines on unseen datasets and no model that consistently led across every dataset. Therefore, an in-domain winner should not be described as the best model for all other studies. The result supports choosing a model for a specified deployment context, not declaring a universal champion.
Use independent or hidden test data when possible
The DREAM drug-sensitivity challenge illustrates the value of reserving hidden gold-standard data from participants. A locked external test prevents repeated tuning against the answers and gives a more honest estimate of transfer. If no hidden set exists, document how often the public test was inspected and treat the resulting estimate as optimistic.
The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Harmonize response labels before comparing studies
Drug-response measurements are products of experimental protocols, concentration ranges and analysis choices. The 2026 review highlights particular difficulty when comparing IC50 or AUDRC values across datasets collected under different conditions.
Document curation decisions
- Record the original assay, concentration points, exposure time and response normalization.
- Keep track of curve-fitting failures, censored IC50 values and extrapolated estimates.
- Specify whether replicate measurements were averaged, median-combined or otherwise summarized.
- Use an explicit conversion or normalization rule only when its assumptions are justified.
- Retain the original values and provenance so another analyst can audit the harmonized label.
Do not treat similarly named endpoints as interchangeable merely because their columns have the same label. If cross-study comparability is uncertain, state that limitation and restrict the claim to the conditions actually tested.
Keep single-agent and combination prediction separate
Single-agent response predicts how one drug affects a biological sample. Combination prediction estimates a joint effect or synergy under a particular combination model. Their labels, experimental designs and decision thresholds differ, so results from one task should not be used as evidence for the other.
Rank #4
- Dual Converters, Infinite Potential：Includes 2× USB C male to USB A female adapters and 2× USB A male to USB C female adapters. Perfect for a wide range of uses—tablets with Bluetooth keyboards, expand USB ports on macbook, and more. Two different converters for all your daily needs
- Next-Level 10Gbps & 3A Charging: No more slow 480Mbps, this usb to usb c adapter has a transfer speed of up to 10Gbps, allowing you to do more transferring in less time. This usb adapter fits both USB A and USB C charger, supporting up to 3A fast charging
- Upgraded Exquisite Craftsmanship: With an aluminum alloy housing and metal connector, the usbc to usb adapter is extremely durable and sturdy. Rigorously tested to withstand more than 10,000 times of plugging and unplugging, ensuring long-lasting performance
- Broad Compatible: The usb c to usb adapter widely supports all USB C/ USB A devices like laptops, tablets, cellphones, car chargers, and phone chargers. Such as compatible with MacBook Pro/Air 2023/2022, Thunderbolt 4/3 Devices,Apple MagSafe Watch 9/8/7/SE/Ultra, iPad Pro 2022/2021, Samsung Galaxy S23/S20/S10, and iPhone 17/16/15 Pro. Plug and play
- Please Note: To reach 10Gbps speed, keep the cable under 3.3 ft. For USB A Male to USB C adapters, try flipping the USB C connector. USB C Male to USB A adapters support bidirectional 10Gbps transfer within 3.3 ft
The 2019 cancer drug-combination community assessment analyzed 11,576 experiments covering 910 combinations and 85 molecularly characterized cancer cell lines. Twenty percent of combinations were poorly predicted by all participating methods in that challenge dataset. That figure describes those experiments and methods; it is not a general failure rate for every combination model or current dataset.
Use the CTRPv2 figures with their scope attached
In the five-dataset 2026 benchmark, the dataset table lists CTRPv2 with 494 drugs, 720 cell lines and 286,665 responses. Those counts describe that benchmark’s curated records, not every version or download of CTRPv2. Cite the dataset version and curation rules whenever you reproduce the comparison.
The other benchmark datasets should likewise be identified by name, release and number of usable responses in your own report. If a value is not stated or cannot be verified for the version used, label it as not stated rather than filling the cell with an estimate.
Make the experiment reproducible
A result is useful only if another team can reconstruct the data selection, features, splits and scoring. The 2026 benchmark reports versioned code and an archived benchmark dataset containing response data, omics features, drug representations and predefined splits. Check the article’s archive and version tags before relying on those resources, because software and availability can change.
Publish a minimum record
- Dataset names, versions, access dates and inclusion or exclusion rules.
- Feature sources, preprocessing order and random seeds.
- Exact train, validation and test identifiers, or a deterministic split script.
- Model configuration, hyperparameters, stopping criteria and hardware-relevant settings.
- Metric definitions, aggregation rules and confidence-interval procedure.
- Per-drug predictions or sufficient summaries to reproduce subgroup analyses.
Use a locked configuration for the final test and separate exploratory plots from prespecified results. Version the code and environment so a future rerun can distinguish a genuine model change from a dependency or dataset update.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Interpret scores as preclinical evidence
Cell-line benchmarks measure predictive agreement with laboratory response labels. The available evidence does not establish that a higher cell-line score improves patient outcomes, treatment selection or survival. Patient tumors contain microenvironmental, pharmacokinetic and clinical factors that are not represented fully in a cell-line assay.
Best Value
- 5-in-1 Connectivity: Equipped with a 4K HDMI port, a 5 Gbps USB-C data port, two 5 Gbps USB-A ports, and a USB C 100W PD-IN port. Note: The USB C 100W PD-IN port supports only charging and does not support data transfer devices such as headphones or speakers.
- Powerful Pass-Through Charging: Supports up to 85W pass-through charging so you can power up your laptop while you use the hub. Note: Pass-through charging requires a charger (not included). Note: To achieve full power for iPad, we recommend using a 45W wall charger.
- Transfer Files in Seconds: Move files to and from your laptop at speeds of up to 5 Gbps via the USB-C and USB-A data ports. Note: The USB C 5Gbps Data port does not support video output.
- HD Display: Connect to the HDMI port to stream or mirror content to an external monitor in resolutions of up to 4K@30Hz. Note: The USB-C ports do not support video output.
- What You Get: Anker 332 USB-C Hub (5-in-1), welcome guide, our worry-free 18-month warranty, and friendly customer service.
Use careful language: “the model predicted the held-out cell-line endpoint under these assay conditions” is supported by a benchmark; “the model will identify the most effective treatment for patients” requires separate patient-level evidence. A clinical claim needs an external patient cohort, a prespecified endpoint and an evaluation design appropriate to that clinical decision.
A step-by-step evaluation protocol
- Write the use-case statement. Name the biological unit, drug scope, endpoint, prediction output and decision the model is intended to support.
- Freeze the dataset. Record release, assay context, response units, feature sources and curation rules.
- Audit leakage risks. Group duplicates, replicates and related records according to the generalization claim.
- Select the split. Use in-dataset, leave-cell-line-out, leave-drug-out or cross-dataset testing as appropriate, and state what is held out.
- Define preprocessing. Fit transformations only on training data and apply the frozen parameters to validation and test data.
- Choose baselines. Include simple predictors and use identical inputs and splits for every model.
- Prespecify metrics. Define direction, threshold, units, aggregation and uncertainty before inspecting test results.
- Train and tune. Use validation data or nested procedures; never tune repeatedly on the final test set.
- Report detail. Show overall, per-drug and relevant subgroup results with sample counts and uncertainty.
- Run external validation. Lock the model, test on an independent dataset and quantify the performance drop.
- Analyze failures. Investigate drugs, assays, doses and biological subgroups with weak predictions instead of hiding them in an average.
- State the boundary. Explain that the result is preclinical unless patient-level clinical utility has actually been tested.
Troubleshoot common evaluation failures
The score is excellent in-dataset but poor elsewhere
Check for study-specific signatures, batch leakage, overlapping cell lines or drugs, and inconsistent response labels. Re-run with grouped splits and report the independent-dataset result as the transfer estimate.
Two papers report incompatible “best” models
Compare endpoint, assay, dataset composition, split, metric direction and aggregation before comparing model names. Different experimental questions can legitimately produce different winners.
Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minutePC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11The aggregate hides a weak treatment
Publish per-drug values, test counts and the performance distribution. Consider whether heavily sampled drugs dominate a pooled score.
Classification accuracy looks high but decisions are poor
Inspect class prevalence, precision–recall performance, calibration and threshold-specific sensitivity and specificity. Reconsider whether the threshold reflects the intended decision.
IC50 values disagree across sources
Compare dose ranges, exposure times, curve fits, censoring and normalization. Preserve provenance and avoid merging values that are not demonstrably comparable.
A model is called clinically useful from cell-line results
Remove the clinical claim unless an appropriate patient-level external evaluation supports it. Describe the result as preclinical predictive performance and specify the assay conditions.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Clear out junk files and repair common Windows errors3Scan for outdated or missing drivers - takes under a minuteQuick Recap
What a high-quality report should let a reader answer
- What exactly was predicted, for which biological unit and for what decision?
- Which endpoint, assay and dose range produced the labels?
- Could information from the test set enter preprocessing or model selection?
- What does the split represent, and which drugs or cell lines were unseen?
- How does the model compare with simple baselines under the same conditions?
- What are the overall, per-drug and subgroup results?
- How much performance was lost on an independent dataset?
- Are the response labels comparable across studies?
- Can the code, data version, splits and metric definitions reproduce the result?
- Is the conclusion limited to preclinical prediction, or is there genuine patient evidence?
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
